Modern management of cardiogenic pulmonary edema

Emergency Medicine Clinics of North America

Volumn 23, Issue 4, 2005, Pages 1105-1125

  Mattu, Amal ^a   Martinez, Joseph P ^a   Kelly, Brian S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; INOTROPIC AGENT; LEVOSIMENDAN; LOOP DIURETIC AGENT; MILRINONE; MORPHINE SULFATE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ACUTE HEART INFARCTION; ANAMNESIS; ANGIONEUROTIC EDEMA; AORTA BALLOON; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BRADYCARDIA; CARDIOGENIC PULMONARY EDEMA; CARDIOVASCULAR SYMPTOM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DIURESIS; DOSE RESPONSE; DRUG CONTRAINDICATION; DYSPNEA; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; EMBRYO DISPOSITION; EMERGENCY MEDICINE; EMERGENCY WARD; EXTRAVASATION; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE PRESSURE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXIA; INTERSTITIUM; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG CAPILLARY PRESSURE; LUNG EDEMA; LUNG FLUID; LUNG GAS EXCHANGE; MEAN ARTERIAL PRESSURE; MORTALITY; NAUSEA AND VOMITING; PATIENT ATTITUDE; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; THORAX RADIOGRAPHY; TRANQUILIZING ACTIVITY; URTICARIA; VALVULAR HEART DISEASE;

EID: 25844508972     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2005.07.005     Document Type: Review

References (118)

1. R.E. Fromm Jr., J. Varon, and L.R. Gibbs Congestive heart failure and pulmonary edema for the emergency physician J Emerg Med 13 1995 71 87
2. A. Mattu Cardiogenic pulmonary edema Current Opinion in Cardiovascular, Pulmonary, and Renal Investigational Drugs 2 2000 9 16
3. A. Mattu, S. Sharma, and A.M. Perkins Pulmonary edema, cardiogenic eMedicine Journal 3 2 2002 http://www.emedicine.com/med/topic1955.htm
4. M.A. Gropper, J.P. Wiener-Kronish, and S. Hashimoto Acute cardiogenic pulmonary edema Clin Chest Med 15 1994 501 515
5. Q. Dao, P. Krishnaswamy, and R. Kazanegra Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J Am Coll Cardiol 37 2001 379 385
6. A. Chait, H.E. Cohen, and L.E. Meltzer The bedside chest radiograph in the evaluation of incipient heart failure Radiology 105 1972 563 566
7. W. Kostuk, J.W. Barr, and A.L. Simon Correlation between the chest film and hemodynamics in acute myocardial infarction Circulation 48 1973 624 632
8. J.T. Chen Radiographic diagnosis of heart failure Heart Dis Stroke 1 1992 58 63
9. R.G. Badgett, C.R. Lucey, and C.D. Mulrow Can the clinical examination diagnose left-sided heart failure in adults? JAMA 277 1997 1712 1719
10. T. Omland Heart failure in the emergency department: is B-type natriuretic peptide a better prognostic indicator than clinical assessment? J Am Coll Cardiol 44 2004 1334 1336
11. P.A. McCullough, J.E. Hollander, and R.M. Nowak Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department Acad Emerg Med 10 2003 198 204
12. G.R. Pesola The use of B-type natriuretic peptide (BNP) to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency department Acad Emerg Med 10 2003 275 277
13. J. Remes, H. Miettinen, and A. Reunanen Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 12 1991 315 321
14. A. Maisel, J.E. Hollander, and D. Guss Primary results of the rapid emergency department heart failure outpatient trial (REDHOT) J Am Coll Cardiol 44 2004 1328 1333
15. S.P. Collins, S. Ronan-Bentle, and A.B. Storrow Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea Ann Emerg Med 41 2003 532 545
16. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 166
17. J. Ishii, M. Nomura, and Y. Nakamura Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure Am J Cardiol 89 2002 691 695
18. A. Harrison, L.K. Morrison, and P. Krishnaswamy B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann Emerg Med 39 2002 131 138
19. L.K. Morrison, A. Harrison, and P. Krishnaswamy Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
20. M.A. Silver, A. Maisel, and C.W. Yancy BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases Congest Heart Fail 10 5, Suppl 3 2004 1 30
21. J.F. Beltrame, C.J. Zeitz, and S.A. Unger Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema J Card Fail 4 1998 271 279
22. W. Buseman, and D. Schupp Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema Am J Cardiol 41 1978 931 936
23. J. Dupuis Nitrates in congestive heart failure Cardiovasc Drugs Ther 8 1994 501 507
24. G.I. Nelson, B. Silke, and R.C. Ahuja Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction Lancet 1 8327 1983 730 733
25. D. Northridge Frusemide or nitrates for acute heart failure? Lancet 347 1996 667 668
26. G. Cotter, E. Metzkor, and E. Kaluski Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet 351 1998 389 393
27. P.A. Kraus, J. Lipman, and P.J. Becker Acute preload effects of furosemide Chest 98 1990 124 128
28. J.R. Hoffman, and S. Reynolds Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema Chest 92 1988 586 593
29. A.D. Timmis, M.T. Rothman, and M.A. Henderson Haemodynamic effect of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure BMJ 280 1980 980 982
30. A. Sacchetti, E. Ramoska, and M.E. Moakes Effect of ED management on ICU use in acute pulmonary edema Am J Emerg Med 17 1999 571 574
31. W.D. Bussmann, and M. Kaltenbach Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema Eur J Cardiol 4 1976 327 333
32. W.D. Bussmann, and D. Schupp Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema Am J Cardiol 41 1978 931 936
33. H.L. Haber, C.L. Simek, and J.D. Bergin Bolus intravenous nitroglycerin predominantly reduces afterload in patients with severe congestive heart failure J Am Coll Cardiol 22 1993 251 257
34. P.R. Imhof, B. Ott, and P. Frankhauser Differences in nitroglycerin dose response in the venous and arterial beds Eur J Clin Pharmacol 18 1980 455 460
35. L.A. Vismara, D.M. Leaman, and R. Zelis The effects of morphine on venous tone in patients with acute pulmonary edema Circulation 54 1976 335 337
36. R. Zelis, E.J. Mansour, and R.J. Capone The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects J Clin Invest 54 1974 1247 1258
37. D.G. Lappas, D. Geha, and J.E. Fischer Filling pressures of the heart and pulmonary circulation of the patient with coronary artery disease after large intravenous doses of morphine Anesthesiology 42 1975 153 159
38. E.A. Amsterdam, R. Zelis, and D.B. Kohfeld Effect of morphine on myocardial contractility: negative inotropic action during hypoxia and reversal by isoproterenol Circulation 43-4 Suppl II 1971 135
39. A. Sacchetti, E. Ramoska, and M.E. Moakes Effect of ED management on ICU use in acute pulmonary edema Am J Emerg Med 17 1999 571 574
40. M. Gammage Treatment of acute pulmonary oedema: diuresis or vasodilatation? Lancet 351 1998 382 383
41. J. Figueras, and M.H. Weil Blood volume prior to and following treatment of acute cardiogenic pulmonary edema Circulation 57 1978 349 355
42. H. Ikram, W. Chan, and E.A. Espiner Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure Clin Sci 59 1980 443 449
43. G.S. Francis, R.M. Siegel, and S.R. Goldsmith Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure Ann Intern Med 103 1985 1 6
44. G.I. Nelson, R.C. Ahuja, and B. Silke Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction Eur Heart J 4 1983 706 711
45. S. Lal, J.G. Murtagh, and A.M. Pollock Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures Br Hear J 31 1969 711 717
46. J. Figueras, and M.H. Weil Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema Am J Cardiol 44 1979 1349 1355
47. R.J. Henning, and M.H. Weil Effect of afterload reduction on plasma volume during acute heart failure Am J Cardiol 42 1978 823 827
48. T.L. Biddle, and P.N. Yu Effect of furosemide on haemodynamic and lung water in acute pulmonary edema secondary to myocardial infarction Am J Cardiol 43 1979 86 90
49. T.P.J. Dormans, P. Pickkers, and F.G.M. Russel Vascular effects of loop diuretics Cardiovasc Res 32 1996 988 997
50. S.K. Mukherjee, M.A. Katz, and U.F. Michael Mechanisms of hemodynamic actions of furosemide: differentiation of vascular and renal effects on blood pressure in functionally anephric hypertensive patients Am Heart J 101 1981 313 318
51. P. Pickkers, T.P.J. Dormans, and P. Smits Direct vasoactivity of frusemide Lancet 347 1996 1338 1339
52. P. Pickkers, T.P. Dormans, and F.G. Russel Direct vascular effects of furosemide in humans Circulation 96 1997 1847 1852
53. L. Gehm, and D.A. Propp Pulmonary edema in the renal failure patient Am J Emerg Med 7 1989 336 339
54. R.E. Schmieder, F.H. Messerli, and J.G.R. deCarvalho Immediate hemodynamic response to furosemide in patients undergoing chronic hemodialysis Am J Kidney Dis 9 1987 55 59
55. H. Mond, D. Hunt, and G. Sloman Haemodynamic effects of frusemide in patients suspected of having acute myocardial infarction Br Heart J 36 1974 44 53
56. D.L. Fett, P.G. Cavero, and J.C. Burnett Jr. Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure J Am Soc Nephrol 4 1993 162 167
57. S.H. Kubo, M. Clark, and J.H. Laragh Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics Am J Cardiol 60 1987 1322 1328
58. J. Kiely, D.T. Kelly, and D.R. Taylor The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction Circulation 48 1973 581 587
59. N. Nishimura, and N. Kanbe The renal and hemodynamic effects of furosemide in acute myocardial infarction Crit Care Med 9 1981 829 832
60. W.S. Colucci, U. Elkayam, and D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 343 2000 246 253
61. R.M. Mills, T.H. LeJemtel, and D.P. Horton Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group J Am Coll Cardiol 34 1999 155 162
62. Publication Committee for the VMAC Investigators Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
63. J.A. Noviasky, M. Kelberman, and K.M. Whalen Science or fiction: use of nesiritide as a first-line agent? Pharmacotherapy 23 2003 1081 1083
64. U. Elkayam, M.W. Akhter, and H. Singh Comparison of effects of left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure Am J Cardiol 93 2004 237 240
65. J.D. Sackner-Bernstein, M. Kowalski, and M. Fox Short-term risk of death after treatment with nesiritide for decompensated heart failure - a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
66. J.D. Sackner-Bernstein, H.A. Skopicki, and K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491
67. J.C. Barnett, K.M. Zink, and R.C. Touchon Sublingual captopril in the treatment of acute heart failure Curr Ther Res 49 1991 274 281
68. D. Annane, E. Bellissat, and E. Pussare Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema Circulation 94 1996 1316 1324
69. M. Haude, W. Steffen, and R. Erbel Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure Int J Cardiol 27 1990 351 359
70. K. Langes, J. Siebels, and K.H. Kuck Efficacy and safety of intravenous captopril in congestive heart failure Curr Ther Res 53 1993 167 176
71. P. Varriale, W. David, and B.E. Chryssos Hemodynamic response to intravenous enalaprilat in patients with severe congestive heart failure and mitral regurgitation Clin Cardiol 16 1993 235 238
72. J.C. Southall, D.M. Bissell, and J.H. Burton ACE inhibitors in acutely decompensated congestive heart failure Acad Emerg Med 11 2004 503
73. F. Brivet, J.F. Delfraissy, and J.F. Giudicelli Immediate effects of captopril in acute left ventricular heart failure secondary to myocardial infarction Eur J Clin Invest 11 1981 369 373
74. H. Tohmo, M. Karanko, and K. Korpilahti Haemodynamic effects of enalaprilat and preload in acute severe heart failure complicating myocardial infarction Eur Heart J 15 1994 523 527
75. R.J. Hamilton, W.A. Carter, and E.J. Gallagher Rapid improvement of acute pulmonary edema with sublingual captopril Acad Emerg Med 3 1996 205 212
76. A. Sacchetti, J. McCabe, and M. Torres ED management of acute congestive heart failure in renal dialysis patients Am J Emerg Med 11 1993 644 647
77. G.M. Felker, and C.M. O'Connor Between Scylla and Charybdis: the choice of inotropic agent for decompensated heart failure Am Heart J 142 2001 932 933
78. G.A. Ewy Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals? J Am Coll Cardiol 33 1999 572 575
79. R.M. Gagnon, L. Fortin, and R. Boucher Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure Chest 78 1980 694 698
80. A. Nohria, E. Lewis, and L.W. Stevenson Medical management of advanced heart failure JAMA 287 2002 628 640
81. P.R. Eisenberg, A.S. Jaffe, and D.P. Schuster Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients Crit Care Med 12 1984 549 553
82. E.C. Keung, S.J. Siskind, and E.H. Senneblick Dobutamine therapy for acute myocardial infarction JAMA 245 1981 144 146
83. C.M. Travill, S. Pugh, and M.I. Noble The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade Clin Ther 16 1994 783 792
84. J.B. Shipley, D. Tolman, and A. Hastillo Milrinone: basic and clinical pharmacology and acute and chronic management Am J Med Sci 311 1996 286 291
85. W.S. Colucci, R.F. Wright, and B.E. Jaski Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness Circulation 73 3 1986 175 183
86. R. Grose, J. Strain, and M. Greenberg Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure J Am Coll Cardiol 7 1986 1107 1113
87. R.P. Karlsberg, M.A. DeWood, and A.N. DeMaria Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group Clin Cardiol 19 1996 21 30
88. A. Kawamura, T. Yoshikawa, and T. Takahashi Randomized trial of phosphodiesterase inhibitors versus catecholamines in patients with acutely decompensated heart failure Jpn Circ J 65 2001 858 862
89. G. Mager, R.K. Klocke, and A. Kux Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure Am Heart J 121 1991 1974 1983
90. M.H. Yamani, S.A. Haji, and R.C. Starling Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact Am Heart J 142 2001 998 1002
91. M.S. Cuffe, R.M. Califf, and K.F. Adams Jr. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
92. J.L. Anderson, J.C. Askins, and E.M. Gilbert Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone Am Heart J 111 1986 466 474
93. P. Varriale, and S. Ramaprasad Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good Pharmacotherapy 17 1997 371 374
94. M.S. Nieminen, J. Akkila, and G. Hasenfuss Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure J Am Coll Cardiol 36 2000 1903 1912
95. M.T. Slawsky, W.S. Colucci, and S.S. Gottlieb Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure Circulation 102 2000 2222 2227
96. F. Follath, J.G. Cleland, and H. Just Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial Lancet 360 2002 196 202
97. A.D. Sacchetti, R.H. Harris, and C. Paston Bi-level positive airway pressure support system use in acute congestive heart failure: preliminary case series Acad Emerg Med 2 1995 714 718
98. T.D. Bradley, R.M. Holloway, and P.R. McLaughlin Cardiac output response to continuous positive pressure in congestive heart failure Am Rev Respir Dis 145 1991 377 382
99. D.M. Baratz, P.R. Westbrook, and P.K. Shah Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure Chest 102 1992 1397 1401
100. M.T. Naughton, M.A. Rahman, and K. Hara Effects of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure Circulation 91 1995 1725 1731
101. A.D. Bersten, A.W. Holt, and A.E. Vedig Treatment of severe cardiogenic pulmonary edema with continuous positive pressure delivered by face mask N Engl J Med 325 1991 1825 1830
102. M. Lin, Y.F. Yang, and H.T. Chiang Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema: short-term results and long-term follow-up Chest 107 1995 1379 1386
103. J. Masip, A.J. Betbese, and J. Paez Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial Lancet 356 2000 2126 2132
104. D. Pang, S.P. Keenan, and D.J. Cook The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema Chest 114 1998 1185 1192
105. J. Rasanen, J. Heikklia, and J. Downs Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema Am J Cardiol 55 1985 296 300
106. H.N. Wigder, P. Hoffmann, and D. Mazzolini Pressure support noninvasive positive pressure ventilation treatment of acute cardiogenic pulmonary edema Am J Emerg Med 19 2001 179 181
107. A.W. Holt, A.D. Bersten, and S. Fuller Intensive care costing methodology: cost benefit analysis of mask continuous positive airway pressure for severe cardiogenic pulmonary oedema Anaesth Intens Care 22 1994 170 174
108. S. Mehta, G.D. Jay, and R.H. Woolard Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema Crit Care Med 25 1997 620 628
109. M.A. Levitt A prospective, randomized trial of BiPAP in severe acute congestive heart failure J Emerg Med 21 2001 363 369
110. A.M. Cross, P. Cameron, and M. Kierce Non-invasive ventilation in acute respiratory failure: a randomized comparison of continuous positive airway pressure and bi-level positive airway pressure Emerg Med J 20 2003 531 534
111. M.P. Grace, and D.M. Greenbaum Cardiac performance and response to PEEP in patients with cardiac dysfunction Crit Care Med 10 1982 358 360
112. M. Hsieh, T.E. Auble, and D.M. Yealy Predicting the future: can this patient with acute congestive heart failure be safely discharged from the emergency department? Ann Emerg Med 39 2002 181 189
113. P. Le Conte, V. Coutant, and J.M. N'Guyen Prognostic factors in acute cardiogenic pulmonary edema Am J Emerg Med 17 1999 329 332
114. G.D. Plotnick, M.H. Kelemen, and R.B. Garrett Acute cardiogenic pulmonary edema in the elderly: factors predicting in-hospital and one-year mortality South Med J 75 1982 565 569
115. M.H. Chin, and L. Goldman Correlates of major complications or death in patients admitted to the hospital with congestive heart failure Arch Intern Med 156 1996 1814 1820
116. J.M. Brophy, G. Deslauriers, and B. Boucher The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure Can J Cardiol 9 1993 219 224
117. G.C. Fonarow, K.F. Adams Jr., and W.T. Abraham Risk stratification for in-hospital mortality in acutely decompensated heart failure JAMA 293 2005 572 580
118. G.M. Felker, W.A. Gattis, and J.D. Leimberger Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure Am J Cardiol 92 2003 625 628